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After birth, the intestinal mucosa undergoes a
dramatic transition from a sterile protected site to
an environmentally exposed and permanently colo-
nized surface. The mechanisms that facilitate this
transition are ill defined. Here, we demonstrate that
microRNA-146a-mediated translational repression
and proteolytic degradation of the essential Toll-
like receptor (TLR) signaling molecule interleukin 1
receptor associated kinase 1 (IRAK1) is sufficient to
induce intestinal epithelial innate immune tolerance
and provide protection from bacteria-induced
epithelial damage in neonates. Despite low IRAK1
protein levels, continuous TLR4- and IRAK1-depen-
dent signal transduction induced by intraepithelial
endotoxin persistence during the neonatal period
maintains tolerance through sustained miR-146a
expression. Strikingly, it additionally facilitates tran-
scription of a distinct set of genes involved in cell
survival, differentiation, and homeostasis. Thus, our
results identify the underlying molecular mecha-
nisms of intestinal epithelial innate immune tolerance
during the neonatal period and characterize toler-
ance as an active condition involved in the establish-
ment of intestinal mucosal homeostasis.
INTRODUCTION
Conserved microbial structures found on commensal and path-
ogenic microbial organisms are recognized by innate immune
receptor molecules. The best-studied family of innate immune
receptors is the family of Toll-like receptors (TLRs). TLRs induce
cell stimulation via a conserved signaling cascade and
contribute to antimicrobial host defense activation but also
inflammation-related tissue damage. Early studies suggested
that TLR expression is restricted to professional immune cells.
During the last few years, however, epithelial cells in various
organs have unambiguously been shown to express TLRs and
significantly contribute to microbial recognition and innate host
defense activation (Andonegui et al., 2003; Lotz et al., 2006;
Schilling et al., 2003).358 Cell Host & Microbe 8, 358–368, October 21, 2010 ª2010 ElsevieTLR signaling in the intestine significantly contributes to anti-
microbial host defense and maintenance of the mucosal barrier
(Cario et al., 2007; Leaphart et al., 2007; Rakoff-Nahoum et al.,
2004; Weiss et al., 2004). In accordance, impaired intestinal
epithelial TLR signaling is associated with inflammation and
mucosal pathology (Franchimont et al., 2004; Nenci et al.,
2007; Zaph et al., 2007). Yet TLR-mediated stimulation by intes-
tinal epithelial cells (IECs) must be controlled to avoid inappro-
priate immune activation by environmental microbial substrates
and the colonizing bacterial flora. Indeed, lack of negative regu-
latory control of innate immune signaling has been shown to
cause inflammation, mucosal damage, and organ dysfunction
(Kobayashi et al., 2002; Nakagawa et al., 2002; Turer et al.,
2008). The understanding of regulatory mechanisms of TLR
signaling has therefore emerged as major field in innate immune
research to explain the maintenance of mucosal homeostasis
under dynamic changes and the presence of functional TLRs
on mucosal, i.e., environment- exposed and microbially
colonized epithelial surfaces (O’Neill, 2008; Sansonetti, 2008;
Shibolet and Podolsky, 2007).
The present study focuses on changes that occur at the
enteric mucosal surface at the transition between fetal, neonatal,
and adult life. During this time, the epithelial surface has to adapt
from the sterile, microbial-restricted site in utero to a highly
environment-exposed and microbially colonized mucosa.
Despite the long list of mechanisms implicated in negative regu-
lation of TLR signaling, the molecular processes that facilitate
this adaptation and establish the intestinal homeostasis are ill
defined. Here, we characterize an example of ontogenetic
restriction of innate immune stimulation and identify the molec-
ular and cellular mechanisms underlying the induction, mainte-
nance, and loss of epithelial tolerance. We finally present the
surprising finding that neonatal intestinal epithelial tolerance
simultaneously induces continuous epithelial signal transduction
and the sustained expression a distinct set of genes involved the
establishment of the neonatal host-microbe homeostasis.
RESULTS
Neonatal Intestinal Epithelial Tolerance Correlates
with IRAK1 Expression In Vivo
Recent work from our group identified a TLR4-mediated tran-
scriptional activation of IECs immediately after birth (Lotz et al.,
2006). This epithelial activation was induced by oral ingestion of
environmental endotoxin and followed by downregulation ofr Inc.
Figure 1. IRAK1 Downregulation Is Sufficient to
Confer Intestinal Epithelial Tolerance
(A) IECs were isolated from small-intestinal tissue
obtained from fully mature c-section-born (fetal) or vagi-
nally delivered mice at the indicated time after birth. Total
cell lysate was examined by immunoblot.
(B) Quantitative RT-PCR for Irak1 mRNA expression in
IECs from fully mature, c-section-born (fetal) or vaginally
delivered mice at the indicated time after birth.
(C) Small-intestinal tissues obtained from fully mature
c-section-born (fetal) or vaginally delivered mice at the
indicated time after birth were incubated in the presence
or absence of LPS (100 ng/mL) for 2 hr at 37C. IECs
were isolated and analyzed for Mip-2 mRNA expression.
(D) Small intestines were obtained from wild-type, Tlr4-, or
Irak1-deficient fully mature c-section-born (fetal)
newborns or vaginally delivered 21-day-old (d21) mice.
After incubation ex vivo in the presence or absence of
LPS (100 ng/ml) for 2 hr at 37C, IECs were isolated and
analyzed for Mip-2 mRNA expression.
Data are representative for three independent experi-
ments and are presented as mean ± SD. See also
Figure S1.
Cell Host & Microbe
Neonatal Intestinal Innate Immune Toleranceepithelial IRAK1 protein expression. Here, we analyzed the
course, underlying molecular mechanisms, and functional con-
sequences of intestinal epithelial IRAK1 downregulation in vivo.
As expected, epithelial IRAK1 protein expression was strongly
downregulatedshortlyafterbirth (Figure1A).Surprisingly, aprevi-
ously nondescribed reappearance of epithelial IRAK1 protein
was noted at the time of weaning at day 21 after birth. No alter-
ation of the Irak1 messenger RNA (mRNA) expression level was
observed, consistent with a solely posttranscriptional mecha-
nism of IRAK1 downregulation (Figure 1B). Importantly, a strict
correlation of IRAK1 expressionwith epithelial endotoxin respon-
siveness could be demonstrated with a recently established
model of ex vivo small-intestinal tissue stimulation with subse-
quent isolation and analysis of highly pure (>98% E-cadherin+;
< 1%CD45+) IECs (Figure 1C and Figures S1A and S1B available
online). The critical role of IRAK1 for epithelial TLR susceptibility
was confirmed by the absence of detectable lipopolysaccharide
(LPS)-induced activation of primary fetal and adult IECs isolated
from Irak1-deficient mice, similar to what was observed in Tlr4-
deficient mice (Figure 1D).Neonatal Intestinal Epithelial Tolerance Protects
from Bacteria-Induced Mucosal Damage
Persistent epithelial IRAK1 expression in the absence of
postnatal transcriptional activation was noted in Caesarean
section (c-section)-born wild-type and vaginally delivered Tlr4-
deficient mice despite luminal exposure to other TLR ligands
(Figure 2A and Figures S2A–S2C). These results illustrated the
particular susceptibility of neonatal IECs to LPS (Figure S2D)
and suggested that TLR signaling-competent IECs of c-
section-born neonates might represent a model to study the
functional consequences of preserved epithelial IRAK1 expres-Cell Hossion in vivo. Therefore, mice were orally challenged with Escher-
ichia coli (E. coli), a gram-negative commensal bacterium found
in maternal feces. As expected, enhanced expression of the
proinflammatory chemokineMip-2was observed upon bacterial
challenge in c-section-born wild-type but not in vaginally deliv-
ered wild-type or c-section-born Tlr4-deficient neonates
(Figure S2E and data not shown). Interestingly, epithelial damage
characterized by a marked apoptosis illustrated by TUNEL
and active caspase 3 staining (Figure 2B), as well as caspase-
induced actin fragmentation (Figure 2C), was noted in c-
section-born mice orally exposed to E. coli, in accordance with
the previously shown apoptosis-promoting role of TLR4 at the
intestinal epithelium of neonates (Leaphart et al., 2007). Impor-
tantly, epithelial apoptosis was only observed in c-section-
born wild-type neonates, whereas vaginally born wild-type or
c-section-born Tlr4-deficient mice were completely protected
(Figures 2C and 2D). The critical role of IRAK1 was confirmed
by the finding that downregulation of epithelial IRAK1 protein
expression in c-section-born neonates by administration of
oral Irak1 small interfering RNA (siRNA; Figures S2F–S2H) pro-
tected from bacteria-induced epithelial damage (Figures 2E
and 2F).miR-146a-Mediated Translational Repression
Is Essential for LPS-Induced Epithelial IRAK1
Downregulation
A diminished response of a 30 untranslated region (UTR) Irak1-
luciferase fusion construct in the presence of miR-146a was
recently demonstrated (Taganov et al., 2006; Nahid et al.,
2009). Strong postnatal induction of epithelial miR-146a expres-
sion was observed in vaginally delivered wild-type but not LPS-
unresponsive Tlr4-deficient neonates (Figure 3A), in accordancet & Microbe 8, 358–368, October 21, 2010 ª2010 Elsevier Inc. 359
Figure 2. Bacteria-Induced Mucosal Damage in Nontolerized Intestinal Epithelium
(A) IRAK1 immunoblot of isolated IECs from vaginally delivered wild-type (WT), c-section-born wild-type, and vaginally born Tlr4-deficient (Tlr4/) mice isolated
at the indicated time after birth.
(B) TUNEL (red, left) and active caspase 3 (red, right) staining of small-intestinal tissue from c-section-born neonates left untreated or orally exposed to E. coli.
Tissues were obtained at 12 hr (active caspase 3) or at the indicated time (TUNEL) after bacterial exposure. Counterstaining with wheat germ agglutinin (WGA,
green) and Dapi (blue). Scale bars represent 100 mm (left) and 200 mm (right).
(C) Immunoblot to detect caspase-induced actin-cleavage in isolated IECs from vaginally delivered wild-type (WT), c-section-born wild-type, and vaginally
delivered Tlr4-deficient (Tlr4/) neonate mice at the indicated time after oral exposure to E. coli (2 3 108 CFU).
(D) Immunohistology for active caspase 3 (red) in intestinal tissue obtained from vaginally delivered wild-type (WT), c-section-born wild-type, and vaginally deliv-
ered Tlr4-deficient (Tlr4/) neonate mice 12 hr after oral challenge with E. coli (2 3 108 CFU). Counterstaining with WGA (green) and DAPI (blue). Scale bars
represent 100 mm.
(E) Immunoblot to detect caspase-induced actin-cleavage in isolated IECs from c-section-born neonates treated with 2 nmol control siRNA (siCo) or Irak1 siRNA
(siIRAK1) prior to oral exposure with E. coli (2 3 108 CFU).
(F) Immunohistology for active caspase 3 (red) in intestinal tissue obtained from c-section-born neonate mice treated with control siRNA (siCo) or Irak1 siRNA
(siIRAK1) prior to oral challenge with E. coli (2 3 108 CFU). Counterstaining with WGA (green) and DAPI (blue). Scale bars represent 100 mm.
Results are representative for three independent experiments and are presented as mean ± SD. See also Figure S2.
Cell Host & Microbe
Neonatal Intestinal Innate Immune Tolerancewith miR-146a induction by the transient epithelial activation
observed after vaginal delivery (Figure S2A). miR-146a levels
remained high during the neonatal period and declined only
during the third week after birth, concomitant to the reappear-
ance of epithelial IRAK1 protein expression and LPS responsive-
ness (Figures 1A and 1C). The level ofmiR-146a also increased in
intestinal epithelial m-ICcl2 cells upon LPS stimulation in a TLR4-,
MyD88-, and NF-kB-dependent manner (Figures S3A and S3B).
The functional importance of miR-146a on epithelial IRAK1 regu-
lation was demonstrated by the finding that miR-146a inhibition
by transfection with anti-miR-146a inhibited IRAK1 protein
downregulation (Figure 3B), enhanced LPS-induced MIP-2360 Cell Host & Microbe 8, 358–368, October 21, 2010 ª2010 Elseviesecretion (Figure 3C), and restored LPS-induced translocation
of the NF-kB subunit p65/RelA in tolerant IECs (Figure 3D).
Oral treatment with fluorophore-labeled anti-miR control
resulted in significant uptake by IECs as illustrated by flow cy-
tometry and histology (Figures S3C and S3D), suggesting that
manipulation of the in vivo levels of epithelial miR-146a might
be possible. Indeed, oral treatment with anti-miR-146a signifi-
cantly reduced the miR-146a expression in miR-146a high
primary IECs from vaginally delivered wild-type neonates
(Figure 3E and Figure S3E). Importantly, diminished miR-146a
expression was sufficient to enhance epithelial IRAK1 protein
levels (Figure 3F) and to render them susceptible to epithelialr Inc.
Figure 3. Translational Repression of Intestinal Epithelial Irak1 by
miR-146a
(A) Quantitative analysis of miR-146a expression in IECs obtained from small-
intestinal tissue of vaginally delivered wild-type and Tlr4-deficient (Tlr4/)
neonates at the indicated time after birth.
(B) Immunoblot for IRAK1 expression in naive and LPS-stimulated (LPS) intes-
tinal epithelial m-ICcl2 cells treated with control miR inhibitor (anti-miR co.,
100 nM) or miR-146a inhibitor (anti-miR-146a, 100 nM).
(C)MIP-2 secretion bym-ICc12 cells left unstimulated (white bars) or stimulated
(black bars) with LPS (10 ng/ml) after treatment with miR control agent (anti-
mIR co., 100 nM) or miR-146a inhibitor (anti-miR 146a, 100 nM).
(D) Immunostaining of the NF-kB p65/RelA subunit. Naive (top) and tolerant
(bottom) intestinal epithelial m-ICcl2 cells were left untreated or stimulated
with LPS (10 ng/ml) in the absence or presence of control miR inhibitor
(anti-miR co., 100 nM) or miR-146a inhibitor (anti-miR-146a, 100 nM). The
scale bar represents 10 mm.
(E) miR-146a expression by primary IECs isolated from vaginally delivered
wild-type (WT VD) or c-section-born wild-type (WT CS) or vaginally delivered
Tlr4-deficient (TLR4/ VD) neonate mice.
(F–H) Inhibition of epithelial miR-146a renders vaginally delivered neonates
susceptible to bacteria-induced epithelial damage.
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Cell Hosapoptosis induced by oral bacterial exposure (Figures 3G and
3H). In addition, the functional consequences of experimentally
enhanced epithelial miR-146a expression in miR-146a low
primary IECs from c-section-born neonates could be demon-
strated in vivo (Figures 3I–3K). Oral administration of Cy3-labeled
miRmimicwas readily internalized by neonatal IECs (Figure S3F),
and administration of miR-146a mimic to c-section-born
neonates resulted in significantly elevated epithelial miR-146a
expression levels (Figure S3G). Elevated epithelial miR-146a
levels reduced epithelial IRAK1 protein expression (Figure 3I)
and protected the epithelium from bacteria-induced apoptosis
(Figures 3J and 3K).Epithelial IRAK1 Protein Is Downregulated
by Proteasomal and Lysosomal Degradation
Since the miR-146a-mediated effect on epithelial IRAK1 expres-
sion was restricted to translational repression, the cellular
process of LPS-induced IRAK1 protein downregulation was
examined in greater detail. Similar to the intestinal epithelium
in vivo, downregulation of IRAK1 expression in intestinal epithe-
lial m-ICcl2 cells was sufficient to abolish TLR signaling
(Figure S4A). Also, IRAK1 expression in m-ICcl2 cells was exclu-
sively regulated on the posttranscriptional level (Figure S4B).
IRAK1 downregulation in IECs might therefore rely on protea-
some-mediated degradation after phosphorylation and ubiquiti-
nation previously described in myeloid cells (Li et al., 2000;
Siedlar et al., 2004). Consistent with published results, IRAK1
degradation and restriction of chemokine secretion in macro-
phages was completely inhibited by proteasomal inhibition
(Figures 4A and 4B). Surprisingly, in IECs, lysosomal inhibitors
in addition to proteasomal inhibitors significantly inhibited
LPS-induced IRAK1 protein degradation (Figure 4A) and
enhanced epithelial chemokine secretion (Figure 4B). Of note,
LPS-induced MIP-2 secretion in intestinal epithelial m-ICcl2 cells(F) Immunoblot for IRAK1 in primary IECs isolated from vaginally delivered (VD)
mice left untreated or orally treated with control miR inhibitor (anti-miR co.,
2 nmol) or miR-146a inhibitor (anti-miR-146a, 2 nmol).
(G) Immunoblot showing actin-cleavage in IECs isolated from E. coli (2 3 108
CFU) exposed vaginally delivered mice orally pretreated with control miR
inhibitor (anti-miR co., 2 nmol) or miR-146a inhibitor (anti-miR-146a, 2 nmol).
(H) Immunohistology for active caspase 3 (red) in intestinal tissue obtained
from anti-miR-co.- or anti-miR-146a-treated vaginally delivered mice orally
exposed to E. coli (2 3 108 CFU). Counterstaining with WGA (green) and
DAPI (blue). Scale bars represent 100 mm.
(I–K) Epithelial miR-146a expression protects c-section born mice from
bacteria-induced damage.
(I) Immunoblot for IRAK1 in primary IECs isolated from c-section-born (CS)
mice left untreated or orally treated with microRNA mimic control (Mimic co.,
2 nmol) or mature miR-146a mimic (miR-146a mimic, 2 nmol).
(J) Immunoblot showing actin-cleavage in IECs isolated from E. coli (2 3 108
CFU) exposed c-section-born mice orally pretreated with microRNA mimic
control (Mimic co., 2 nmol) or mature miR-146a mimic (miR-146a mimic,
2 nmol).
(K) Immunohistology for active caspase 3 (red) in intestinal tissue obtained
from microRNA mimic control (Mimic co., 2 nmol) or mature miR-146a mimic
(miR-146a mimic, 2 nmol)-treated c-section-born mice orally exposed to
E. coli (23 108 CFU). Counterstaining withWGA (green) and DAPI (blue). Scale
bars represent 100 mm.
Data are representative for two to three independent experiments and are
presented as mean ± SD. **p < 0.01. See also Figure S3.
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Figure 4. Signaling-Induced Proteasomal
and Lysosomal Degradation of Epithelial
IRAK1
(A) Immunoblot for IRAK1 and ubiquitin (m-ICcl2
cells) or IRAK1 (RAW264.7 cells) under nonstimu-
lated or LPS-stimulated (100 ng/ml) conditions in
the absence or presence of the proteasomal inhib-
itor MG132 (100 nM), the lysosomal inhibitors
concanamycin A (Conc A, 200 nM) and leupeptin
(200 mg/ml), as well as the kinase inhibitor K252b
(25 mM).
(B) MIP-2 secretion by intestinal epithelial m-ICcl2
cells and macrophage-like RAW264.7 cells upon
LPS stimulation (100 ng/ml) in the absence or
presence of the indicated inhibitors.
(C) Immunoblot for IRAK1 in primary IECs isolated
from c-section-born (f, fetal) or 1-day-old vaginally
delivered (VD) mice left untreated or orally treated
with a combination of the proteasomal and
lysosomal inhibitors MG132 and concanamycin
A (2 mM and 4 mM, respectively, in 3 ml).
(D and E) Immunoblot showing actin-cleavage in
isolated IECs (D) and immunohistology for active
caspase 3 (red) in intestinal tissue obtained both
from 1-day-old vaginally delivered mice left
untreated or orally exposed to a combination of
the proteasomal and lysosomal inhibitors MG132
and concanamycin A (2 mM and 4 mM, respec-
tively, in 3 ml) with or without E. coli (2 3 108
CFU) (E). Counterstaining was performed with
WGA (green) and DAPI (blue). P/L inh., protea-
some/lysosome inhibitors. Scale bars represent
100 mm.
Data are representative for three independent
experiments and are presented as mean ± SD.
See also Figure S4.
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is also mediated by the mitogen activated protein (MAP) kinase
Erk (data not shown). The functional relevance of proteasomal
and lysosomal degradation of epithelial IRAK1 for endotoxin
tolerance was also illustrated in vivo: vaginally delivered
neonates orally treated with proteasome and lysosome inhibitors
maintained epithelial IRAK1 protein expression (Figure 4C). Also,
this treatment rendered apoptosis-resistant vaginally born mice
susceptible to E. coli-induced neonatal epithelial apoptosis
(Figures 4D and 4E).
Intracellular Ligand Persistence and Continuous
TLR4- and IRAK1-Dependent Signaling in Tolerant IECs
Epithelial innate immune tolerance is observed throughout the
neonatal period, and the mechanisms that maintain IRAK1
downregulation during these 2 weeks after birth are unresolved.
Continuous IRAK1 degradation appears to occur since protea-
somal or lysosomal inhibition even at prolonged time points after
tolerization resulted in a rapid rise of IRAK1 protein (Figure S5A).
Unexpectedly, rapid activation of tolerant epithelial m-ICcl2 cells
was observed after blockage of proteasomal and lysosomal
IRAK1 degradation in a TLR4-dependent fashion even in the
absence of LPS in the culture medium (Figure 5A). Similar results
were also obtained in primary IECs isolated from 10-day-old
neonates. Proteasomal or lysosomal inhibition led to reappear-
ance of IRAK1 expression (Figure S5B) and spontaneous epithe-362 Cell Host & Microbe 8, 358–368, October 21, 2010 ª2010 Elsevielial activation in the absence of exogenously added LPS
(Figure 5B). The TLR4 dependency of the epithelial activation
after inhibition of IRAK1 degradation suggested the prolonged
presence of the TLR4 ligand LPS in tolerant IECs. Indeed, intra-
cellular persistence of LPS was detected in m-ICcl2 cells after
a short initial exposure, in accordance with previous reports
(Figure 5C) (Hornef et al., 2002). The requirement of TLR4
signaling-induced proteolytic IRAK1 degradation for tolerance
maintenance was confirmed by the striking finding that inhibition
of Tlr4 expression by siRNA treatment after tolerization readily
induced reappearance of IRAK1 protein expression (Figure 5D).
Epithelial tolerance thus appears not to be a passive, unrespon-
sive condition but rather to represent an active process of
ongoing TLR4 signaling-mediated proteolytic IRAK1 degrada-
tion caused by ligand persistence and continuous TLR4
stimulation.
Continuous TLR4-mediated signal transduction might also
contribute to the sustained miR-146a expression during the
neonatal period (Figure 3A). Indeed, treatment of tolerant
m-ICcl2 cells with Tlr4 siRNA but not control siRNA significantly
reduced the level of miR146a expression (Figure 5E). Also,
miR-146a expression in primary neonatal IECs was significantly
reduced by oral administration of Tlr4 siRNA (Figure 5F). Surpris-
ingly, sustained miR-146a expression in tolerant cells was also
reduced by Irak1 siRNA treatment, revealing the surprising
finding of continuous TLR4- and IRAK1-dependent signalingr Inc.
Figure 5. Continuous TLR4- and IRAK1-Dependent Signal Transduction in Tolerant IECs
(A) MIP-2 secretion by naive or tolerant (1 mg/ml for 6 hr, then fresh medium for 36 hr) intestinal epithelial m-ICcl2 cells incubated in the absence or presence of the
proteasomal inhibitor MG132 (100 nM) or the lysosomal inhibitor concanamycin A (Conc A, 200 nM) and left untreated or treated after tolerization with siRNA to
downregulate Tlr4 expression.
(B) Quantitative RT-PCR forMip-2mRNA expression in IECs isolated from small-intestinal tissue of 10-day-old vaginally delivered mice incubated in the absence
or presence of the proteasomal inhibitor MG132 (100 nM) or/and the lysosomal inhibitor concanamycin A (Conc A, 200 nM) for 2 hr.
(C) m-ICcl2 cells were exposed to biotin-conjugated LPS and intraepithelial LPS was visualized with Cy3-conjugated streptavidin (red). Counterstaining with phal-
loidin-FITC (green) and DAPI (blue). The scale bar represents 5 mm.
(D) Immunoblot for IRAK1 in naive and tolerant intestinal epithelial m-ICcl2 cells left untreated or treated after tolerizationwith siRNA to downregulate Tlr4 expression.
(E) Quantitative analysis of miR-146a expression in naive or tolerant intestinal epithelial m-ICcl2 cells subsequently treated with control siRNA (siCo), Tlr4 siRNA
(siTlr4), or Irak1 siRNA (siIrak1) and incubated for 24 hr.
(F) Quantitative analysis of miR-146a expression in IECs isolated from intestinal tissue of 1-day-old vaginally delivered neonates after oral treatment with control
siRNA (siCo), Tlr4 siRNA (siTlr4), or Irak1 siRNA (siIrak1).
(G) Left: Schematic illustration of the expression of a selected set of genes in LPS-stimulated (100 ng/ml) intestinal epithelial m-ICcl2 cells at high IRAK1 protein
levels (IRAK1high) 6 hr after stimulation or at IRAK1 low protein levels (IRAK1low) 96 hr after stimulation. The values represent the mean of three measurements and
present the relative expression level as compared to unstimulated cells. Right: Schematic illustration of the relative distribution of the function of genes induced
by LPS under IRAK1high or IRAK1low conditions.
(H) Quantitative RT-PCR expression analysis of genes induced under IRAK1high conditions (6 hr LPS, top) and IRAK1low conditions (1 mg/ml LPS for 6 hr, then
fresh medium for 36 hr, bottom). TLR4- and IRAK1-dependent gene induction and miR-146a-dependent gene repression were demonstrated by administration
of Tlr4 and Irak1 siRNA or miR-146a inhibitor (anti-miR-146a, 100 nM), respectively.
(I) Quantitative RT-PCR expression analysis of selected genes such as Cxcl2 (Mip2) and Cxcl5 (top) and Slc2a1, St3gal1, Bhlhb2, and Cldn4 (bottom) in primary
isolated IECs from 1-day-old vaginally delivered (VD) neonates. Mice were left untreated or were treated orally with Tlr4 siRNA (siTlr4), Irak1 siRNA (siIrak1), or
miR-146a inhibitor (anti-miR-146a, 100 nM) directly after birth as indicated.
Data are presented as mean ± SD. **p < 0.01. See also Figure S5.
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in vitro and in vivo (Figures 5E and 5F). Thus, ligand-induced
continuous TLR4-mediated signal transduction and miR-146a
expression in tolerant cells critically involves IRAK1.
Continuous TLR4/IRAK1 signaling in tolerant cells might also
lead to transcriptional activation of coding mRNAs and the
synthesis of functionally relevant gene products. Therefore,
whole-genome expression analysis was performed comparing
LPS-induced gene expression in intestinal epithelial m-ICcl2 cells
under high IRAK1 protein levels (IRAK1high, i.e., 6 hr after stimu-
lation) versus under low IRAK1 protein levels (IRAK1low, i.e., 96 hr
after stimulation). A relatively small number of genes was signif-
icantly induced 6 hr after TLR4-dependent stimulation at
IRAK1high conditions, whereas a surprisingly large gene group
exhibited significant upregulation exclusively in tolerant cells
under IRAK1low conditions (Figure 5G, left panel). Importantly,
whereas most IRAK1high-dependent genes such as chemokines,
transcription factors, innate immune receptors were involved in
inflammation and immune stimulation, the majority of
IRAK1low-dependent genes were associated with cell survival
and proliferation, metabolism, or development and differentia-
tion (Figure 5G, right panel). The TLR4- and IRAK1-dependent
expression of selected genes was subsequently confirmed by
quantitative RT-PCR under IRAK1high and IRAK1low conditions.
The chemokines CXCL2 (MIP2) and CXCL5 (MCP) exhibited
TLR4- and IRAK1-dependent upregulation 6 hr after LPS stimu-
lation (IRAK1high) but were absent in a miR-146a-dependent
fashion in tolerant (IRAK1low) cells (Figure 5H, upper panel).
In contrast, the glucose transporter (Slc2A10), the sialyl-trans-
ferase involved in plasma membrane decoration and cell-cell
interaction (ST3 beta-galactoside alpha-2,3-sialyltransferase 1,
ST3gal1), the tight junction component claudin 4 (Cldn4), and
the differentation factor basic helix-loop-helix domain containing
protein class 2B (Bhlhb2) were absent at LPS-induced IRAK1high
conditions but exhibited a strong TLR4- and IRAK1-dependent
expression in tolerant, IRAK1low epithelial m-ICcl2 cells
(Figure 5H, lower panel). A similar situation was also found
in vivo on day 1 after vaginal delivery. Whereas IRAK1high genes
were not expressed (Figure 5I, upper panel), all selected IRA-
K1low genes revealed strong upregulation (Figure 5I, lower
panel). Oral administration of Tlr4 siRNA, Irak1 siRNA, or anti-
miR-146a after birth significantly reduced the gene expression,
confirming the requirement of TLR4- and IRAK1-dependent
signal transduction and translational repression of Irak1 mRNA
for the expression of IRAK1low dependent genes in tolerant IECs.
Loss of Intracellular Endotoxin Reverts the Tolerant
Epithelial Phenotype
Profound changes within the intestinal mucosa occur during the
third week of the neonatal development. Increased epithelial
proliferation at this time initiates the well-described continuous
IEC renewal of the adult intestinal epithelium associated with
migration along the crypt-villus axis and exfoliation at the villus
tip (Barker et al., 2008). A possible link between cellular prolifer-
ation as well as reappearance of IRAK1 expression and loss of
tolerance was therefore examined. Tolerant intestinal epithelial
m-ICcl2 cells cultured under low-proliferating conditions
remained completely LPS nonresponsive, whereas IECs kept
under high-proliferating conditions for a similar time rapidly364 Cell Host & Microbe 8, 358–368, October 21, 2010 ª2010 Elsevieregained LPS susceptibility (Figure 6A and Figure S6A). Since
continuous LPS-induced TLR4 signaling was shown to cause
tolerance maintenance, the endotoxin concentration was
measured in total cell lysate of both groups. As expected, a rapid
decrease of intracellular LPS was found in high-proliferating
cells, whereas unaltered LPS concentrations were measured in
low-proliferating IECs (Figure 6B). Accordingly, nonproliferating
cells maintained high miR-146a expression and low IRAK1
protein levels during the observed time, whereas in high-prolifer-
ating IECs miR-146a expression returned to baseline and IRAK1
expression reappeared precisely when LPS concentrations
reached baseline values (Figures 6C and 6D). Strikingly, a similar
scenario was also observed in vivo. LPS administered orally to
neonate mice at one occasion during the first 2 hr after birth
could be visualized in IECs in tissue sections obtained at 1, 3,
6, and even at 14 days after birth. At 21 days after birth, however,
with the reappearance of epithelial IRAK1 expression and LPS
susceptibility, no intraepithelial LPS was detected anymore
(Figure 6E). The age-dependent loss of intraepithelial LPS was
confirmed with LPS quantification by the limulus assay
(Figure 5F). Importantly, loss of intraepithelial LPS coincided
with enhanced intestinal epithelial proliferation between 14 and
21 days after birth, as illustrated by markedly enhanced immu-
nostaining for the cell division marker Ki67 (Figure 5G).
DISCUSSION
Here, we describe intestinal innate immune tolerance as an
example of ontogenetic alteration of innate immune recognition
that protects the intestinal epithelium from inappropriate
immune activation during the neonatal period. Exposure to
microbial ligands both from the colonizing microflora and the
environment is a hallmark of IECs as a consequence of their
anatomical localization. This is particularly evident during the
postnatal period, when the sterile and protected fetal gut
mucosa becomes exposed to the environment and has to adapt
to facilitate a stable lifelong host-microbial homeostasis. This is
in sharp contrast to professional immune cells such as
macrophages that reside in a sterile environment and are only
exposed to microbial ligands in the context of an invasive
infection or breakage of surface barriers. Although innate
immune tolerance is also observed in other cell types, important
features underlying the initiation, maintenance, and release of
endotoxin tolerance investigated in the present study are unique
to IECs and therefore warrant careful analysis to understand their
contribution in the establishment of intestinal mucosal homeo-
stasis.
Mucosal damage was observed in nontolerized c-section-
born neonates after oral exposure to bacteria of the maternal
enteric microflora. Since the developing intestinal microflora
can resemble themother’s enteric flora, oral ingestion of bacteria
from the maternal feces appears to be a realistic scenario
(Palmer et al., 2007). Bacteria-induced induction of TLR4-depen-
dent epithelial apoptosis is also in accordance with previous
reports on TLR4-mediated epithelial damage (Aliprantis et al.,
1999; Leaphart et al., 2007; Palazzo et al., 2008). This finding
might have great clinical relevance, since intestinal epithelial
apoptosis is a hallmark of necrotizing enterocolitis (NEC), the
leading cause of death in low-weight human neonates. Ther Inc.
Figure 6. Loss of Intraepithelial Endotoxin Terminates Intestinal Epithelial Tolerance
(A) MIP-2 concentration in cell culture supernatant from untreated naive (co.), LPS-stimulated naive (LPS, 10 ng/mL for 6 hr), untreated tolerant (tol. co.; 1 mg/ml
LPS for 6 hr, then fresh medium for 36 hr), or LPS-stimulated tolerant (tol. LPS; 1 mg/ml LPS for 6 hr, then fresh medium for 36 hr followed by stimulation with
10 ng/mL LPS for 6 hr) m-ICcl2 cells cultured under low-proliferating (low prolif., top) or high-proliferating (high prolif., bottom) conditions for the indicated time.
(B–D) LPS quantification (B), IRAK1 immunoblot (C), and miR-146a expression (D) in total cell lysate of naive (co., white) or tolerant (Tol., black, 1 mg/ml LPS for
6 hr, then fresh medium for 36 hr) m-ICcl2 cells cultured under high-proliferating (high prolif, squares) or low-proliferating (low prolif., circles) conditions for the
indicated time.
(E) Immunostaining for intraepithelial intestinal LPS in small-intestinal tissue of mice left untreated (Co) or orally challenged with LPS (LPS, 3 mg in 10 ml) at a single
occasion during the first 2 hr after birth. Small-intestinal tissues were obtained at the indicated age (days, d) and stained with an anti-LPSO-antigen antibody. The
scale bar represents 100 mm.
(F) LPS quantification in total cell lysate of IECs isolated from small-intestinal tissue of untreated c-section-born mice (fetal) or orally LPS challenged (3 mg in
10 ml directly after birth) vaginally delivered 10-day-old (d10) and 21-day-old (d21) mice.
(G) Immunostaining for the proliferationmarker Ki67 (red) in small-intestinal tissue ofmice at the indicated time after birth (days, d). Counterstaining with phalloidin
(green) and DAPI (blue). The scale bar represents 100 mm.
Results are presented as mean ± SD. **p < 0.01. See also Figure S6.
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Neonatal Intestinal Innate Immune Toleranceetiology of NEC is incompletely understood but has been linked
to premature birth, disbalanced bacterial colonization, and
disturbed TLR signaling (Jilling et al., 2004; Leaphart et al.,
2007). Our data thus provide a possible explanation how an inap-
propriate epithelial innate immune response of the neonate
intestine in the absence of sufficient regulatory control might
result in epithelial damage and disease. The results using oral
administration of siRNA, anti-microRNA, or mimic microRNA
further suggest possible novel strategies to interfere with dysre-
gulated tolerance induction and prevent inappropriate innate
immune stimulation.Cell HosAlthough epithelial tolerance protects from tissue damage
during bacterial colonization, it also restricts the ability to mount
an adequate antibacterial host defense in the event of infection.
Yet under physiological conditions, neonates exclusively feed
from milk, a safe source of food associated with little if any risk
to acquire enteropathogenic microorganisms. The situation
changes with oral uptake of potentially contaminated solid
food, which is first observed during the third week after birth.
At this time point, the intestinal mucosa has undergone signifi-
cant changes. Intestinal crypts have formed generating a pro-
tected anatomical niche for the intestinal epithelial stem cellst & Microbe 8, 358–368, October 21, 2010 ª2010 Elsevier Inc. 365
Cell Host & Microbe
Neonatal Intestinal Innate Immune Tolerance(Barker et al., 2008). The continuous epithelial proliferation and
migration along the crypt-villus axis with exfoliation at the villus
tips has started that regularly renews the intestinal epithelium
(Skrzypek et al., 2005). The epithelial synthesis of the cathelici-
din-related antimicrobial peptide (CRAMP) has vanished, and
the production of high levels of a-defensins and cryptdin-related
sequence (CRS) peptides by Paneth cells situated in the newly
formed intestinal crypts has started (Me´nard et al., 2008). The
mucus layer has been accomplished and the mucosal surface
has been colonized, and a stable microbial flora has been estab-
lished (Palmer et al., 2007). Although the underlying mechanisms
are not completely understood, these changes seem to restrict
stimulation of adult IECs by luminal microbial ligands under
physiological conditions illustrated by persistent IRAK1 protein
expression and lack of miR-146a expression in healthy adult
intestinal epithelium. Nevertheless, adult IECs exhibit TLR4
responsiveness under certain conditions, in accordance with
previous reports on TLR-dependent signaling along the adult
intestinal mucosa in response to microbial exposure (Cario
et al., 2007; Leaphart et al., 2007; Rakoff-Nahoum et al., 2004)
or bacterial infection (Weiss et al., 2004).
IRAK1 phosphorylation, ubiquitination, and degradation are
prerequisites of both signal transduction and tolerance induction
(Schauvliege et al., 2007). Whereas IRAK1 degradation in
myeloid cells is restricted to the proteasome, we show that
both proteasomal and lysosomal degradation contribute to
epithelial IRAK1 downregulation. This is in accordance with the
recent observation of lysosomal targeting of cytoplasmic ubiqui-
tinated proteins (Kim et al., 2008). Yet only proteolytic degrada-
tion with simultaneous translational repression of Irak1 mRNA
allows tolerance induction. Translational repression is caused
by enhanced miR-146a expression induced by the recently
discovered postnatal epithelial activation and maintained by
ongoing signal transduction in tolerant cells (Lotz et al., 2006).
IRAK1 has previously been proposed to represent a direct
molecular target of the inducible miR-146a, and a binding
sequence within the 30 UTR of Irak1 has been identified (Taganov
et al., 2006; Nahid et al., 2009). Thus, our results confirm these
results and extend the functional relevance of miR-146a medi-
ated regulation of innate immune signaling in vivo (Nakasa
et al., 2008; Perry et al., 2008). The reported inhibitory effect of
mIR-146a on both TLR4 signaling molecules IRAK1 and TRAF6
illustrates the potency of the regulatory circuit examined and
further stresses the importance of tight control of innate immune
signaling (Taganov et al., 2006). The upstream localization of
IRAK1 in the TLR signaling cascade, however, precluded a
separate functional analysis of TRAF6 in our study. The solely
translational repression of IRAK1 in IECs without detectable
degradation of Irak1mRNA might represent an intestinal epithe-
lial-specific feature of miR-146a biology (Taganov et al., 2006).
Since IRAK1 is critically involved in the MyD88-dependent
signaling pathway of all TLRs (as well as the interkeukin-1
[IL-1] and IL-18 receptor) loss of IRAK1 causes what has previ-
ously been named cross-tolerance. In turn, also other TLR
ligands might principally be able to induce or at least contribute
to epithelial tolerance. In contrast to the well-established role
of LPS, however, their ability to persist intracellularly and there-
fore to provide continuous epithelial signaling is undefined (Lotz
et al., 2006).366 Cell Host & Microbe 8, 358–368, October 21, 2010 ª2010 ElsevieStrikingly, tolerance represents an active condition with high
turnover of IRAK1 protein and continuous signaling rather than
a simple downregulation to block inappropriate activation. In
addition, continuous signal transduction in tolerant IECs facili-
tates expression of a distinct set of LPS-induced genes associ-
ated with cell proliferation, metabolism, and differentiation, as
well as epithelial cell adhesion and cytoskeleton formation, sug-
gesting that intestinal epithelial innate immune tolerance signifi-
cantly contributes to the neonatal establishment of the enteric
homeostasis after birth. Inhibition of IRAK1 degradation in
tolerant, LPS-bearing IECs converts the unresponsive pheno-
type leading to ‘‘spontaneous’’ activation. This activation occurs
without additional endotoxin exposure but is driven by intracellu-
larly stored ligand via TLR4. This finding stresses the functional
relevance of the recently identified intracellular localization of
TLR4 in IECs (Hornef et al., 2002) and has a surprising and poten-
tially important functional consequence: any agent causing
impairment of IRAK1 degradation in tolerant cells might experi-
mentally appear as TLR4 ligand.
In conclusion, our data identify neonatal intestinal epithelial
innate immune tolerance as an example of ontogenetic restric-
tion of innate immune signaling to prevent bacteria-induced
intestinal epithelial damage during the transition between fetal,
neonatal, and adult life. Our findings further identify miR-146a-
mediated translational repression of Irak1mRNA as central regu-
lator of epithelial TLR4 signaling and characterize intestinal
epithelial tolerance as a transcriptionally active condition to
support the establishment of intestinal mucosal homeostasis.EXPERIMENTAL PROCEDURES
Mouse Experiments and Cell Isolation
C57BL/6 mice were purchased from Charles River Breeding Laboratories,
housed under specific pathogen-free conditions, and treated in accordance
with the local animal protection legislation (Regierungspra¨sidium Stuttgart
and Niedersa¨chsisches Landesamt fu¨r Verbraucherschutz und Lebensmittel-
sicherheit Oldenburg, 07/1269 and 07/1268a). Tlr4-deficient C57BL/10ScN
mice were generously provided by Marina Freudenberg (Max Planck-Institute
of Immunobiology, Freiburg, Germany) and Irak1-deficient C57BL/6 mice by
J. Thomas (University of Texas Southwestern Medical Center, Dallas, TX)
and Anne Krug (University Clinic, Technical University Munich, Munich,
Germany). C-section was performed with full-term gravid females. For
ex vivo stimulation, small-intestinal tissue was removed, extensively rinsed,
and incubated with 100 ng/ml LPS at 37C for the indicated time. Subse-
quently, IECs were isolated as previously described, and total mRNA was
prepared (Lotz et al., 2006). This method differed from the previously used
assay protocol facilitating stimulation of IECs within the preserved cell-cell
andbasalmembrane contacts (Yamada et al., 2009). Also, it prevented a signif-
icant influence of the isolation procedure on cellular responsiveness, since
stimulation was performed first and the cell isolation was largely accomplished
at 4C. The purity of primary isolated IECs was verified by FACS analysis
(Figure S1A). For oral bacterial challenge, c-section-born wild-type mice or
vaginally delivered wild-type or Tlr4-deficient mice were orally exposed to
2 3 108 CFU Escherichia (E.) coli in 3 ml bicarbonate buffer and kept under
infrared light. Prior to bacterial challenge, some vaginally delivered mice or
c-section-born mice were orally treated with Concanamycin A and MG132
or anti-microRNA (Cy3 dye-labeled anti-miR negative control or anti-miR-
146a inhibitor, Ambion), or mature microRNA mimics (miRIDIAN microRNA
mimic transfection control with Cy3 or mmu-miR-146a miRIDIANmimic, Dhar-
macon RNAi Technologies), or predesigned siRNAs (Genomewide siRNA,
QIAGEN) in a total volume of 3 ml. Mice were sacrificed at the indicated time
points, the intestinal tissues were removed, and IECs were isolated. For in vivo
intraepithelial LPS measurements, C57BL/6 neonates were fed during the firstr Inc.
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murium LPS (Enzo Life Sciences International, Plymouth Meeting, PA).
mRNA Analysis
First-strand complementary DNAs (cDNAs) were synthesized from Trizol
(Invitrogen)-extracted total RNA with oligo-dT primers, and real-time PCRs
were performed with a mixture prepared with absolute QPCR ROX mix
(Thermoscientific), sample cDNA, intron-spanning forward and reverse
primers, and the 6-carboxy-fluorescein-conjugated target probe provided in
the commercial TaqMan gene expression assay for murine hypoxanthine
phosphoribosyltransferase (Hprt), Mip-2, and Irak1 (Applied Biosystems).
Slc2a1, Claudine 4, St3gal1, Bhlhb2, Cxcl2, Cxcl5, and GapdhmRNA expres-
sion was quantified with a SybrGreen-based (Molecular Probes, Eugene, OR)
RT-PCR employing primers listed in the Supplemental Information.
MicroRNAs were isolated with the mirVana miRNA Isolation Kit (Ambion).
Target-specific stem loop structure and reverse transcription primers were
used (TaqMan microRNA assay, Applied Biosystems), and after reverse tran-
scription with the TaqMan MicroRNA Reverse Transcription Kit (Applied
Biosystem), TaqMan 23 Universal PCR Master Mix (No AmpErase UNGb,
Applied Biosystems) and specific TaqMan hybridization probes were used
to quantify miR-146a expression (TaqManmiR-146amicroRNA assay, Applied
Biosystems). The small RNA snoRNA202 was amplified as internal control
(TaqMan snoRNA202 assay, Applied Biosystems). Analyses were performed
with an ABI PRISM Sequence Detection System 7000 (Applied Biosystems).
Each sample was amplified in duplicate and normalized to the endogenous
control. Results were calculated by use of the 2-DDCT method and are
presented as fold induction of target gene transcripts in stimulated relative
to unstimulated controls. Global gene expression analysis was performed in
triplicate using a mouse whole-transcript expression analysis microarray
(Affymetrix, High Wycombe, UK) to compare differentially expressed genes
in intestinal epithelial m-ICcl2 cells stimulated with LPS for 6 hr (IRAK1
high) or
stimulated with LPS for 6 hr and subsequently incubated with fresh medium
for 90 hr (IRAK1low) and normalized to nonstimulated m-ICcl2 cells. Genes ex-
hibiting at least a 3.0-fold difference in the expression level were considered to
be significantly regulated.
Cell Culture Assays
m-ICcl2 cells and RAW 264.7 cells were cultured as described (Bens et al.,
1996; Lotz et al., 2006). Escherichia coli K12 D31m4 LPS (List Biological Labo-
ratories) was used for stimulations. Purity of the LPS preparation was
confirmed by complete absence of stimulating activity on peritoneal macro-
phages isolated from Tlr4-deficient mice. Toxins and inhibitors were preincu-
bated for 30 min prior to LPS stimulation at the following concentrations:
MG-132, 100 nM; leupeptin, 200 mg/ml (Sigma-Aldrich); concanamycin, 200
nM (Alexis Biochemicals); SN50, 18 mM; and K-252b, 25 mM (Enzo Life
Sciences International). RNA silencing was performed with predesigned siR-
NAs (Flexitubes siRNA, QIAGEN) for Tlr4, Irak, and Myd88 and a universal
negative control (final concentration 10 nM). For miRNA silencing, a miR inhib-
itor against miR-146a (mmu-mir-146a) was used together with a Cy3-labeled
negative control miR inhibitor (Ambion) at a final concentration of 100 nM as
previously described (Chassin et al., 2007). For in vitro intracellular LPS
measurements, m-ICcl2 cells were tolerized with 1 mg/ml LPS during 6 hr,
washed three times, and subsequently cultured either under low-proliferating
conditions at a confluency of 100% or under high-proliferating conditions
with repeated passages every other day (each passage seeded at20% con-
fluency).
Immunoblot and Endotoxin Quantification
Immunoblotting was performed as recently described (Lotz et al., 2006). Anti-
bodies against IRAK1 (mousemonoclonal, Santa Cruz Biotechnology), ubiqui-
tin (mouse monoclonal, Cell Signaling Technology), and b-actin- (N-terminal
domain, Sigma-Aldrich, Taufenkirchen, Germany) were used in combination
with peroxidase-labeled goat-anti-mouse or goat-anti-rabbit secondary
antibodies (Jackson ImmunoResearch). The specificity of the anti-IRAK1 anti-
body was confirmed with siRNA-treated m-ICcl2 cells (Figure S6B) and IECs
isolated from Irak1-deficient mice (Figure S6C). MIP-2 in cell culture superna-
tant was determined by ELISA (Nordic Biosite, Ta¨by, Sweden) as describedCell Hospreviously (Hornef et al., 2002). LPS was quantified with the chromogenic
QCL-1000 limulus amebocyte lysate assay (BioWhittaker).
Immunostaining
Immunostaining for active caspase 3 (Cell Signaling Technology, Danvers,MA)
and TUNEL (Roche Diagnostics, Mannheim, Germany) was performed as
recommended by the manufacturer. Immunostaining of Salmonella (S.) enter-
ica subsp. enterica sv. Typhimurium LPS was performed with two mouse
monoclonal biotin-labeled anti-O4 and anti-O5 antibodies kindly provided by
M. Kim (Kim Laboratories, Champaign, IL), followed by incubation with Cy3-
conjugated streptavidin (Jackson ImmunoResearch Laboratories). The cell
division protein Ki67 was visualized with a polyclonal rabbit antiserum
(1:2000) kindly provided by T. Scholzen (Research Center Borstel, Germany)
and detected with a TR-conjugated anti-rabbit secondary antibody (1:50,
Jackson ImmunoResearch). Counterstaining was performed with fluores-
cein-conjugated wheat germ agglutinin (WGA, 1:2000, Vector, Burlingame,
CA) or MFP488 phalloidin (1:50, MoBiTec, Go¨ttingen, Germany) as indicated.
Slides were mounted in DAPI containing Vectashield (Vector) and visualized
with an ApoTome-equipped Axioplan 2microscope connected to an AxioCam
Mr digital Camera (Carl Zeiss MicroImaging, Jena, Germany).
Statistics
Results are expressed as means ± SD and represent at least three similar
experiments. Differences were analyzed with the unpaired Student’s t test.
p < 0.05 was considered significant.
Accession numbers
The expression array data are accessible through GEO Series accession
number GSE23755.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and one table and can be found
with this article online at doi:10.1016/j.chom.2010.09.005.
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